Equity Research, Broker Reports, and media content on Cello Health

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Cello Health
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Cello Health

Company Profile

  • Personnel
  • Mark Scott, CEO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Cello Health. We currently have 108 research reports from 6 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 100/165p
  • Daily Volume: N/A
  • Daily Liquidity: 0.0%
  • # Shares: 0m
  • Market Cap: £0m
  • Latest PE (hist): 12.32
  • Div Yield: 1.82
Date Source Announcement
11Aug20 10:07 RNS Scheme of Arrangement becomes Effective
11Aug20 07:30 RNS Suspension - Cello Health Plc
10Aug20 12:12 RNS Relevant Securities in Issue
10Aug20 08:54 RNS Exercise of Options
07Aug20 15:04 RNS Court Sanction of Scheme
07Aug20 12:52 RNS Additional Block Listing of Ordinary Shares
04Aug20 17:30 RNS Cello Health
  • Frequency of research reports

     

  • Research reports on

    Cello Health

  • Providers covering

    Cello Health